Literature DB >> 33746014

Nucleic acid delivery with extracellular vesicles.

Michaela Schulz-Siegmund1, Achim Aigner2.   

Abstract

Extracellular vesicles (EVs) are membrane-enclosed particles, heterogeneous in size, shape, contents, biogenesis and structure. They are released by eukaryotic and prokaryotic cells and exert (patho-)physiological roles as mediators for transmitting molecular information from the producer (donor) to a recipient cell. This review focuses on the potential of EVs for delivering nucleic acids, as particularly problematic cargoes with regard to stability/protection and uptake efficacy. It highlights important properties of EVs for nucleic acid delivery and discusses their physiological and pathophysiological roles with regard to various cellular RNA species. It then describes the application of EVs for delivering a broad selection of nucleic acids/oligonucleotides, in particular giving a comprehensive overview of preclinical in vivo studies and the various strategies explored. In this context, different techniques for EV loading are discussed, as well as other important technical aspects related to EV preparation, characterization and in particular, the various approaches of artificial EV modification.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AntimiR; EV; Hybrid EVs; RNA delivery; miRNA

Year:  2021        PMID: 33746014     DOI: 10.1016/j.addr.2021.03.005

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  7 in total

Review 1.  Non-viral vectors for RNA delivery.

Authors:  Yi Yan; Xiao-Yu Liu; An Lu; Xiang-Yu Wang; Lin-Xia Jiang; Jian-Cheng Wang
Journal:  J Control Release       Date:  2022-01-10       Impact factor: 9.776

Review 2.  Emerging micro-nanotechnologies for extracellular vesicles in immuno-oncology: from target specific isolations to immunomodulation.

Authors:  Nna-Emeka Onukwugha; Yoon-Tae Kang; Sunitha Nagrath
Journal:  Lab Chip       Date:  2022-09-13       Impact factor: 7.517

3.  Microvesicles transfer mitochondria and increase mitochondrial function in brain endothelial cells.

Authors:  Anisha D'Souza; Amelia Burch; Kandarp M Dave; Aravind Sreeram; Michael J Reynolds; Duncan X Dobbins; Yashika S Kamte; Wanzhu Zhao; Courtney Sabatelle; Gina M Joy; Vishal Soman; Uma R Chandran; Sruti S Shiva; Nidia Quillinan; Paco S Herson; Devika S Manickam
Journal:  J Control Release       Date:  2021-08-24       Impact factor: 11.467

4.  Mesenchymal stem cell-derived extracellular vesicles prevent the development of osteoarthritis via the circHIPK3/miR-124-3p/MYH9 axis.

Authors:  Shenglong Li; Jie Liu; Siyu Liu; Weijie Jiao; Xiaohong Wang
Journal:  J Nanobiotechnology       Date:  2021-06-30       Impact factor: 10.435

5.  Extracellular vesicle-mediated delivery of circDYM alleviates CUS-induced depressive-like behaviours.

Authors:  Xiaoyu Yu; Ying Bai; Bing Han; Minzi Ju; Tianci Tang; Ling Shen; Mingyue Li; Li Yang; Zhao Zhang; Guoku Hu; Jie Chao; Yuan Zhang; Honghong Yao
Journal:  J Extracell Vesicles       Date:  2022-01

6.  miR-146a-5p-modified hUCMSC-derived exosomes facilitate spinal cord function recovery by targeting neurotoxic astrocytes.

Authors:  Xunwei Lai; Yang Wang; Xiaokang Wang; Bin Liu; Limin Rong
Journal:  Stem Cell Res Ther       Date:  2022-09-30       Impact factor: 8.079

7.  Exosomal miR-140-5p inhibits osteogenesis by targeting IGF1R and regulating the mTOR pathway in ossification of the posterior longitudinal ligament.

Authors:  Yifan Tang; Yanqing Sun; Junkai Zeng; Bo Yuan; Yin Zhao; Xiangwu Geng; Lianshun Jia; Shengyuan Zhou; Xiongsheng Chen
Journal:  J Nanobiotechnology       Date:  2022-10-15       Impact factor: 9.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.